HTRA2 and kidney failure: With HtrA2/Omi and UCH-L1, we have also revealed two novel targets for therapeutic intervention, which may assist in developing strategies for the treatment of damage induced by necroptosis/programmed necrosis (e.g. in organs such as the kidney and the brain, caused by stroke or kidney failure).